The Valley Desk

NCT06470763 · Interventional trial

A Study Evaluating ANV600 Single Agent or in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (EXPAND-1)

Overall registry status Completed

Phase 1 · Phase 2

Conditions Advanced Solid Tumor

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov